Literature DB >> 9786286

Precision and accuracy of self-measured peak expiratory flow rates in chronic obstructive pulmonary disease.

G H Murata1, D J Lium, H K Busby, C O Kapsner.   

Abstract

BACKGROUND: The precision and accuracy of self-measured peak expiratory flow rates (PEFR) have not been determined for patients with chronic obstructive pulmonary disease (COPD).
METHODS: Twenty-eight male veterans recorded their PEFR twice daily, before and after bronchodilators, for 6 months. Spirometry was also done in the pulmonary function laboratory up to 11 times per patient during the observation period. A 4-week "baseline" was identified for each patient. Baseline coefficients of variation (CV) were calculated for the morning (AM) and evening (PM) PEFR, before (PRE) and after (POST) bronchodilators.
RESULTS: The baseline CVs for AMPRE, AMPOST, PMPRE and PMPOST were 14.9+/-6.9%, 12.6+/-5.6%, 14.9+/-4.8%, and 11.2+/-6.0%, respectively. There were strong correlations between self-measured PEFR and values obtained in the pulmonary function laboratory on the same day.
CONCLUSIONS: Self-measured PFFRs are reasonably precise and accurate in patients with COPD.

Entities:  

Mesh:

Year:  1998        PMID: 9786286     DOI: 10.1097/00007611-199810000-00005

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

1.  Daily Peak Expiratory Flow Rate and Disease Instability in Chronic Obstructive Pulmonary Disease.

Authors:  Jennifer Y So; Alejandra C Lastra; Huaqing Zhao; Nathaniel Marchetti; Gerard J Criner
Journal:  Chronic Obstr Pulm Dis       Date:  2015-11-11

2.  Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease?

Authors:  R Perez-Padilla; W M Vollmer; J C Vázquez-García; P L Enright; A M B Menezes; A S Buist
Journal:  Int J Tuberc Lung Dis       Date:  2009-03       Impact factor: 2.373

3.  Once Daily Versus Overnight and Symptom Versus Physiological Monitoring to Detect Exacerbations of Chronic Obstructive Pulmonary Disease: Pilot Randomized Controlled Trial.

Authors:  Ahmed M Al Rajeh; Yousef Saad Aldabayan; Abdulelah Aldhahir; Elisha Pickett; Shumonta Quaderi; Jaber S Alqahtani; Swapna Mandal; Marc Ci Lipman; John R Hurst
Journal:  JMIR Mhealth Uhealth       Date:  2020-11-13       Impact factor: 4.773

4.  Case-finding of chronic obstructive pulmonary disease with questionnaire, peak flow measurements and spirometry: a cross-sectional study.

Authors:  Bassam Mahboub; Ashraf Alzaabi; Joan B Soriano; Laila Salameh; Yousef A L Mutairi; Afzalhussein A Yusufali; Alawi Alsheikh-ali; Wael Almahmeed; John Haughney
Journal:  BMC Res Notes       Date:  2014-04-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.